Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 29.21% vs 111.74% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 80.97% vs 145.73% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 50.50% vs 73.14% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 180.85% vs -21.67% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Speciality Medi. With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
75.29
85.74
-10.45
-12.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
75.29
85.74
-10.45
-12.19%
Raw Material Cost
0.00
49.61
-49.61
-100.00%
Purchase of Finished goods
65.07
2.25
62.82
2,792.00%
(Increase) / Decrease In Stocks
-10.94
-0.84
-10.10
-1,202.38%
Employee Cost
1.73
15.16
-13.43
-88.59%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
5.75
12.50
-6.75
-54.00%
Total Expenditure (Excl Depreciation)
61.61
78.68
-17.07
-21.70%
Operating Profit (PBDIT) excl Other Income
13.68
7.06
6.62
93.77%
Other Income
0.83
1.17
-0.34
-29.06%
Operating Profit (PBDIT)
14.51
8.23
6.28
76.31%
Interest
1.32
0.84
0.48
57.14%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
13.19
7.39
5.80
78.48%
Depreciation
0.17
1.59
-1.42
-89.31%
Profit Before Tax
13.02
5.81
7.21
124.10%
Tax
-0.01
0.00
-0.01
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.03
5.81
7.22
124.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.03
5.81
7.22
124.27%
Equity Capital
8.79
29.46
-20.67
-70.16%
Face Value
10.00
10.00
0.00
Reserves
62.41
91.39
-28.98
-31.71%
Earnings per share (EPS)
14.82
1.97
12.85
652.28%
Diluted Earnings per share
20.11
1.97
18.14
920.81%
Operating Profit Margin (Excl OI)
18.17%
8.23%
0.00
9.94%
Gross Profit Margin
17.52%
8.62%
0.00
8.90%
PAT Margin
17.31%
6.78%
0.00
10.53%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 75.29 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 29.21% vs 111.74% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 13.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 80.97% vs 145.73% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 50.50% vs 73.14% in Mar 2025
Annual - Interest
Interest 1.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 180.85% vs -21.67% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.17%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






